Provides information about the ability of each individual to metabolize and activate each therapeutic agent to its effective form in a normal rate; This test includes all the therapeutic agents with anticancer activity (cytostatics).
Cancer
ChemoSNiP
This test predicts drug activation and deactivation, shows the relationship between the SNP and a clinical condition, predicts the development of certain diseases (like cardiovascular disease and type 2 diabetes) and shows the preferred response to specific categories of substances.
Research Genetics Cancer Centre, Greece
